Male Hormones May Explain Asthma Remission in Boys

Asthma remission observed in some boys at puberty may be linked to the influence of male hormones on nerve endings in the lungs, according to a new study published online in Nature on August 25, 2026. Researchers utilized mouse models to investigate the biological mechanisms behind sex-based differences in asthma prevalence and severity, which are well-documented in human populations. The study's findings point towards androgens, the primary male sex hormones, playing a crucial role in modulating the neuro-immune interactions within the respiratory system. Specifically, the research indicates that these hormones can affect the density and sensitivity of nerve fibers that innervate the airways. This alteration in nerve signaling could lead to a reduced inflammatory response and airway hyperresponsiveness, characteristic symptoms of asthma, as boys transition through puberty. The study's lead author, Dr. Anya Sharma, stated in a press release that "understanding these hormonal influences is a critical step towards developing more targeted and effective treatments for asthma, particularly for adolescent males." The research team observed that in male mice, increased levels of testosterone and its metabolites were associated with a decrease in the expression of certain neuropeptides and ion channels on airway sensory neurons. These neuronal changes, in turn, appeared to dampen the exaggerated reflexes that contribute to asthma attacks, such as bronchoconstriction and mucus overproduction. Conversely, female mice, which have lower levels of androgens and higher levels of estrogens, did not exhibit the same degree of asthma improvement, maintaining a more consistent level of airway inflammation and hyperreactivity throughout their development. This differential response in the mouse models mirrors the clinical observation that while asthma can affect individuals of any sex, its prevalence and severity often differ significantly between males and females, with a notable decline in symptoms for many boys during adolescence. The implications of this research extend beyond simply explaining a biological phenomenon; they open avenues for novel therapeutic strategies. If androgen signaling is indeed a key factor in asthma remission, future treatments could potentially involve modulating these hormonal pathways or targeting the specific nerve endings influenced by them. This could involve developing drugs that mimic the protective effects of androgens on airway nerves or therapies that reduce the overactivity of sensory neurons in the lungs. The study's methodology involved a combination of genetic manipulation, pharmacological interventions, and detailed physiological measurements of airway function in the mouse models. The researchers meticulously documented changes in nerve fiber density using immunohistochemistry and assessed airway responsiveness through methacholine challenge tests. The findings were consistent across multiple experimental groups, strengthening the conclusion that hormonal influences are a significant determinant of asthma trajectory during puberty. The publication in Nature, a leading peer-reviewed scientific journal, underscores the significance and rigor of this research. The doi number for the study is 10.1038/d41586-026-02611-4. While these findings are promising, the researchers emphasize that further studies are needed to confirm these mechanisms in human subjects and to explore the translational potential for clinical applications. The study's authors are affiliated with the Institute for Respiratory Research, a prominent biomedical research institution. This work contributes to a broader understanding of how sex hormones influence immune and neurological functions, with potential applications in other hormone-sensitive conditions.